{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:50:18Z","timestamp":1790524218612,"version":"4.1.0"},"reference-count":84,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical and cytogenetic features associated with T-cell acute lymphoblastic leukemia (T-ALL) are not predictive of early treatment failure. Based on the hypothesis that microarrays might identify patients who fail therapy, we used the Affymetrix U133 Plus 2.0 chip and prediction analysis of microarrays (PAM) to profile 50 newly diagnosed patients who were treated in the Children's Oncology Group (COG) T-ALL Study 9404. We identified a 116-member genomic classifier that could accurately distinguish all 6 induction failure (IF) cases from 44 patients who achieved remission; network analyses suggest a prominent role for genes mediating cellular quiescence. Seven genes were similarly upregulated in both the genomic classifier for IF patients and T-ALL cell lines having acquired resistance to neoplastic agents, identifying potential target genes for further study in drug resistance. We tested whether our classifier could predict IF within 42 patient samples obtained from COG 8704 and, using PAM to define a smaller classifier for the U133A chip, correctly identified the single IF case and patients with persistently circulating blasts. Genetic profiling may identify T-ALL patients who are likely to fail induction and for whom alternate treatment strategies might be beneficial.<\/jats:p>","DOI":"10.1182\/blood-2006-12-059790","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T01:23:05Z","timestamp":1178846585000},"page":"1429-1438","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group"],"prefix":"10.1182","volume":"110","author":[{"given":"Stuart S.","family":"Winter","sequence":"first","affiliation":[{"name":"Departments ofPediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadya M.","family":"Khawaja","sequence":"additional","affiliation":[{"name":"Pathology, The University of New Mexico Health Sciences Center, Albuquerque;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Griffin","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Memorial Hospital of South Bend, IN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[{"name":"Children's Oncology Group and University of Florida, Gainesville;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Asselin","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, University of Rochester Medical Center and Golisano Children's Hospital at Strong, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Larson","sequence":"additional","affiliation":[{"name":"Pathology, The University of New Mexico Health Sciences Center, Albuquerque;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713264556800_B1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"key":"2019111713264556800_B2","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2401555","article-title":"Significance of commonly used prognostic factors differs for children with T-cell acute lymphoblastic leukemia (ALL) compared with those with B-precursor ALL: a Pediatric Oncology Group Study.","volume":"13","author":"Pullen","year":"1999","journal-title":"Leukemia"},{"key":"2019111713264556800_B3","first-page":"735","article-title":"Biology and treatment of childhood T-Lineage acute lymphoblastic leukemia.","volume":"91","author":"Uckun","year":"1998","journal-title":"Blood"},{"key":"2019111713264556800_B4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1182\/blood.V75.1.166.166","article-title":"Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study.","volume":"75","author":"Shuster","year":"1990","journal-title":"Blood"},{"key":"2019111713264556800_B5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMe048154","article-title":"Childhood leukemia: new advances and challenges.","volume":"351","author":"Winick","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111713264556800_B6","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","article-title":"Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.","volume":"99","author":"Willemse","year":"2002","journal-title":"Blood"},{"key":"2019111713264556800_B7","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood.V96.7.2543","article-title":"New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases [In Process Citation].","volume":"96","author":"Schneider","year":"2000","journal-title":"Blood"},{"key":"2019111713264556800_B8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1200\/JCO.1998.16.4.1270","article-title":"Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.","volume":"16","author":"Heerema","year":"1998","journal-title":"J Clin Oncol"},{"key":"2019111713264556800_B9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.leu.2402736","article-title":"Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.","volume":"17","author":"Bj\u00f6rklund","year":"2003","journal-title":"Leukemia"},{"key":"2019111713264556800_B10","first-page":"1126","article-title":"Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.","volume":"87","author":"Gameiro","year":"2002","journal-title":"Haematologica"},{"key":"2019111713264556800_B11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"2019111713264556800_B12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2019111713264556800_B13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","article-title":"Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.","volume":"108","author":"Breit","year":"2006","journal-title":"Blood"},{"key":"2019111713264556800_B14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.leu.2401768","article-title":"Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.","volume":"14","author":"Griffin","year":"2000","journal-title":"Leukemia"},{"key":"2019111713264556800_B15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented postinduction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.","volume":"338","author":"Nachman","year":"1998","journal-title":"N Engl J Med"},{"key":"2019111713264556800_B16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.leu.2403167","article-title":"Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients.","volume":"18","author":"Kohlmann","year":"2004","journal-title":"Leukemia"},{"key":"2019111713264556800_B17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/gcc.10225","article-title":"Molecular characterization of acute leukemias by use of microarray technology.","volume":"37","author":"Kohlmann","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"2019111713264556800_B18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"2019111713264556800_B19","first-page":"3118","article-title":"Identification of gene expression profiles that segregate patients with childhood leukemia.","volume":"8","author":"Moos","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2019111713264556800_B20","first-page":"1149","article-title":"The childhood leukemias.","volume-title":"Comprehensive Textbook of Oncology","author":"Wienstein","year":"1986"},{"key":"2019111713264556800_B21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pbc.20550","article-title":"Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.","volume":"47","author":"Raetz","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"2019111713264556800_B22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111713264556800_B23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"2019111713264556800_B24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"2019111713264556800_B25","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1073\/pnas.96.23.13264","article-title":"cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.","volume":"96","author":"Khan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713264556800_B26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia.","volume":"350","author":"Valk","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111713264556800_B27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.","volume":"350","author":"Bullinger","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111713264556800_B28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"2019111713264556800_B29","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood-2003-09-3243","article-title":"Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.","volume":"103","author":"Chiaretti","year":"2004","journal-title":"Blood"},{"key":"2019111713264556800_B30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.onc.1206131","article-title":"Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins.","volume":"22","author":"Rushton","year":"2003","journal-title":"Oncogene"},{"key":"2019111713264556800_B31","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1373\/clinchem.2004.033225","article-title":"Evaluation of quality-control criteria for microarray gene expression analysis.","volume":"50","author":"Dumur","year":"2004","journal-title":"Clin Chem"},{"key":"2019111713264556800_B32","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.leu.2404274","article-title":"Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks.","volume":"20","author":"Staal","year":"2006","journal-title":"Leukemia"},{"key":"2019111713264556800_B33","unstructured":"National Institutes of Health GEO database. Accesssed July 10, 2007 http:\/\/www.ncbi.nlm.nih.gov\/geo."},{"key":"2019111713264556800_B34","unstructured":"European Bioinformatics Institute, European Molecular Biology Laboratory ArrayExpress database. Accesssed July 10, 2007 http:\/\/www.ebi.ac.uk\/arrayexpress."},{"key":"2019111713264556800_B35","unstructured":"National Cancer Institute, National Institutes of Health caARRAY database. Accesssed July 10, 2007 http:\/\/gedp.nci.nih.gov\/gedp_temp_page.html."},{"key":"2019111713264556800_B36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data.","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"2019111713264556800_B37","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression.","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713264556800_B38","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","article-title":"Childhood leukemias.","volume":"332","author":"Pui","year":"1995","journal-title":"N Engl J Med"},{"key":"2019111713264556800_B39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<600::AID-CNCR24>3.0.CO;2-4","article-title":"Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features randomized controlled trial from the Children's Cancer Group.","volume":"82","author":"Steinherz","year":"1998","journal-title":"Cancer"},{"key":"2019111713264556800_B40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrg1749","article-title":"Microarray data analysis: from disarray to consolidation and consensus.","volume":"7","author":"Allison","year":"2006","journal-title":"Nat Rev Genet"},{"key":"2019111713264556800_B41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.291.65.1","article-title":"A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.","volume":"65","author":"Fine","year":"2005","journal-title":"Cancer Res"},{"key":"2019111713264556800_B42","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ejca.2005.02.026","article-title":"Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.","volume":"41","author":"Kaspers","year":"2005","journal-title":"Eur J Cancer"},{"key":"2019111713264556800_B43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2164-6-59","article-title":"Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR: how well do they correlate?","volume":"6","author":"Dallas","year":"2005","journal-title":"BMC Genomics"},{"key":"2019111713264556800_B44","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.leu.2404270","article-title":"Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients.","volume":"20","author":"Frank","year":"2006","journal-title":"Leukemia"},{"key":"2019111713264556800_B45","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood-2003-01-0338","article-title":"Classification of pediatric acute lymphoblastic leukemia by gene expression profiling.","volume":"102","author":"Ross","year":"2003","journal-title":"Blood"},{"key":"2019111713264556800_B46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","article-title":"Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.","volume":"102","author":"Ferrando","year":"2003","journal-title":"Blood"},{"key":"2019111713264556800_B47","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2003-07-2577","article-title":"Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.","volume":"103","author":"Ferrando","year":"2004","journal-title":"Blood"},{"key":"2019111713264556800_B48","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"2019111713264556800_B49","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1200\/JCO.1998.16.3.920","article-title":"Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.","volume":"16","author":"Nachman","year":"1998","journal-title":"J Clin Oncol"},{"key":"2019111713264556800_B50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04584.x","article-title":"Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia.","volume":"123","author":"Chessells","year":"2003","journal-title":"Br J Haematol"},{"key":"2019111713264556800_B51","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019111713264556800_B52","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-06-0606","article-title":"Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia\/lymphoma.","volume":"12","author":"Cohen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2019111713264556800_B53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/14796694.2.4.441","article-title":"Nelarabine: efficacy in the treatment of clinical malignancies.","volume":"2","author":"Roecker","year":"2006","journal-title":"Future Oncol"},{"key":"2019111713264556800_B54","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/blood-2003-01-0317","article-title":"Mechanisms for T-cell selective cytotoxicity of arabinosylguanine.","volume":"102","author":"Rodriguez","year":"2003","journal-title":"Blood"},{"key":"2019111713264556800_B55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ni1024","article-title":"Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.","volume":"5","author":"Muppidi","year":"2004","journal-title":"Nat Immunol"},{"key":"2019111713264556800_B56","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.4049\/jimmunol.173.10.6151","article-title":"Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production.","volume":"173","author":"Fan","year":"2004","journal-title":"J Immunol"},{"key":"2019111713264556800_B57","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/blood.V95.10.3199","article-title":"RasGRP links T-cell receptor signaling to Ras.","volume":"95","author":"Ebinu","year":"2000","journal-title":"Blood"},{"key":"2019111713264556800_B58","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V90.3.1226","article-title":"Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.","volume":"90","author":"Dibenedetto","year":"1997","journal-title":"Blood"},{"key":"2019111713264556800_B59","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.leu.2402636","article-title":"Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.","volume":"16","author":"van der Velden","year":"2002","journal-title":"Leukemia"},{"key":"2019111713264556800_B60","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood-2004-04-1552","article-title":"Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia.","volume":"105","author":"Cario","year":"2005","journal-title":"Blood"},{"key":"2019111713264556800_B61","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/pbc.20722","article-title":"Childhood acute lymphoblastic leukemia in the age of genomics.","volume":"46","author":"Carroll","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"2019111713264556800_B62","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood-2005-08-3482","article-title":"Transcriptional regulatory networks downstream of TAL1\/SCL in T-cell acute lymphoblastic leukemia.","volume":"108","author":"Palomero","year":"2006","journal-title":"Blood"},{"key":"2019111713264556800_B63","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.4049\/jimmunol.166.4.2394","article-title":"A critical role for CD2 in both thymic selection events and mature T cell function.","volume":"166","author":"Sasada","year":"2001","journal-title":"J Immunol"},{"key":"2019111713264556800_B64","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1182\/blood.V88.11.4288.4288","article-title":"CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.","volume":"88","author":"Uckun","year":"1996","journal-title":"Blood"},{"key":"2019111713264556800_B65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pbc.20429","article-title":"Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.","volume":"46","author":"Winter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"2019111713264556800_B66","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/(SICI)1097-0215(19980316)75:6<855::AID-IJC7>3.0.CO;2-U","article-title":"Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids.","volume":"75","author":"Wartenberg","year":"1998","journal-title":"Int J Cancer"},{"key":"2019111713264556800_B67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gde.2005.12.008","article-title":"Stem cells in the etiology and treatment of cancer.","volume":"16","author":"Zhang","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"2019111713264556800_B68","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.4049\/jimmunol.170.9.4612","article-title":"TGF-beta 1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes.","volume":"170","author":"Bommireddy","year":"2003","journal-title":"J Immunol"},{"key":"2019111713264556800_B69","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1038\/sj.onc.1206603","article-title":"Lats2, a putative tumor suppressor, inhibits G1\/S transition.","volume":"22","author":"Li","year":"2003","journal-title":"Oncogene"},{"issue":"pt 1","key":"2019111713264556800_B70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bj3420163","article-title":"Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells.","volume":"342","author":"Mou","year":"1999","journal-title":"Biochem J."},{"key":"2019111713264556800_B71","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1349-7006.2001.tb01178.x","article-title":"Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.","volume":"92","author":"Beck","year":"2001","journal-title":"Jpn J Cancer Res"},{"key":"2019111713264556800_B72","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1158\/0008-5472.CAN-04-1978","article-title":"Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes.","volume":"64","author":"Gillet","year":"2004","journal-title":"Cancer Res"},{"key":"2019111713264556800_B73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10245330310001638974","article-title":"Pharmacogenomics of MDR1\/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies.","volume":"9","author":"Jamroziak","year":"2004","journal-title":"Hematology"},{"key":"2019111713264556800_B74","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2005.03.002","article-title":"Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.","volume":"7","author":"Lugthart","year":"2005","journal-title":"Cancer Cell"},{"key":"2019111713264556800_B75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3570321","article-title":"Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.","volume":"357","author":"Aslanian","year":"2001","journal-title":"Biochem J"},{"key":"2019111713264556800_B76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bj3580059","article-title":"Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.","volume":"358","author":"Aslanian","year":"2001","journal-title":"Biochem J"},{"key":"2019111713264556800_B77","first-page":"1086","article-title":"Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1\/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.","volume":"94","author":"Leith","year":"1999","journal-title":"Blood"},{"key":"2019111713264556800_B78","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice.","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"2019111713264556800_B79","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-200544040-00003","article-title":"Pharmacokinetic\/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.","volume":"44","author":"Avramis","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"2019111713264556800_B80","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/002215540305100603","article-title":"Enhanced serine palmitoyltransferase expression in proliferating fibroblasts, transformed cell lines, and human tumors.","volume":"51","author":"Carton","year":"2003","journal-title":"J Histochem Cytochem"},{"key":"2019111713264556800_B81","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1073\/pnas.0401851102","article-title":"Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells.","volume":"102","author":"Levchenko","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713264556800_B82","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data.","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2019111713264556800_B83","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1200\/JCO.1997.15.6.2222","article-title":"Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.","volume":"15","author":"Nachman","year":"1997","journal-title":"J Clin Oncol"},{"key":"2019111713264556800_B84","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","article-title":"Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.","volume":"105","author":"Rocha","year":"2005","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/5\/1429\/1294496\/zh801707001429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/5\/1429\/1294496\/zh801707001429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T19:40:16Z","timestamp":1683834016000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/110\/5\/1429\/23808\/Identification-of-genomic-classifiers-that"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-12-059790","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}